Hyung-Ki Kim
Net worth: 29 M $ as of 2026-05-30
Net worth: 29 M $ as of 2026-05-30
Currently, Hyung-Ki Kim occupies the position of Chief Executive Officer & Director at Celltrion Healthcare Co., Ltd. In the past Mr. Kim held the position of Co-Chief Executive Officer & Director at Celltrion, Inc. and Head-Strategic Planning at Daewoo Motor Co.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELLTRION, INC. 0.1% | 2026-06-03 | 227,242 ( 0.1% ) | 29 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CELLTRION, INC. | Director/Board Member | 2005-03-31 |
| CELLTRION HEALTHCARE CO., LTD. | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Chief Executive Officer | - |
Nexolsystem Ltd. | Director/Board Member | - |
Daewoo Motor Co.
Daewoo Motor Co. Motor VehiclesConsumer Durables Manufactures automobiles | Corporate Officer/Principal | - |
| CELLTRION PHARM, INC. | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Daewoo Motor Co.
Daewoo Motor Co. Motor VehiclesConsumer Durables Manufactures automobiles | Consumer Durables |
Celltrion Pharm Inc.
Celltrion Pharm Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Celltrion Healthcare Co., Ltd.
Celltrion Healthcare Co., Ltd. BiotechnologyHealth Technology Develops and sells monoclonal antibody biosimilars for the treatment of cancer | Health Technology |
Celltrion, Inc.
Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Nexolsystem Ltd. |
Select your edition
All financial news and data tailored to specific country editions